Platelet-activating factor receptor-deficient mice show an unaltered clearance of nontypeable Haemophilus influenzae from their respiratory tract

Shock

Volumn 22, Issue 6, 2004, Pages 543-547

  Branger, Judith ^a   Wieland, Catharina W ^a   Florquin, Sandrine ^a   Maris, Nico A ^a   Pater, Jennie M ^a   Speelman, Peter ^a   Shimizu, Takao ^b   Ishii, Satoshi ^b,c   Van Der Poll, Tom ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF TOKYO   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Bacterial infection; Inflammation; Innate host defense; Mice; PAFR

Indexed keywords

GLYCEROPHOSPHOLIPID; MYELOPEROXIDASE; PHOSPHORYLCHOLINE; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CELL WALL; BACTERIAL PNEUMONIA; CELL TYPE; CONTROLLED STUDY; ENZYME ACTIVITY; HAEMOPHILUS INFLUENZAE; HOST RESISTANCE; IN VITRO STUDY; INFLAMMATION; INOCULATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECEPTOR INTRINSIC ACTIVITY; RESPIRATORY EPITHELIUM; RESPIRATORY SYSTEM; WILD TYPE;

ANIMALS; CHEMOKINES; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; LUNG; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PEROXIDASE; PLATELET MEMBRANE GLYCOPROTEINS; RECEPTORS, G-PROTEIN-COUPLED; RESPIRATORY SYSTEM;

EID: 9644289520     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000142818.91693.73     Document Type: Article

References (47)

1. Kuijpers TW, van der Poll T: The Role of PAF in Endotoxin-Related Disease. New York: Marcel Dekker Inc., 1999.
2. Ishii S, Shimizu T: Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice. Prog Lipid Res 39:41-82, 2000.
3. Prescott SM, Zimmerman GA, Stafforini DM, McIntyre TM: Platelet-activating factor and related lipid mediators. Annu Rev Biochem 69:419-445, 2000.
4. Mariano F, Bussolati B, Migliori M, Russo S, Triolo G, Camussi G: Platelet-activating factor synthesis by neutrophils, monocytes, and endothelial cells is modulated by nitric oxide production. Shock 19:339-344, 2003.
5. Bulger EM, Arbabi S, Garcia I, Maier RV: The macrophage response to endotoxin requires platelet activating factor. Shock 17:173-179, 2002.
6. Fischer W: Phosphocholine of pneumococcal teichoic acids: role in bacterial physiology and pneumococcal infection. Res Microbiol 151:421-427, 2000.
7. Risberg A, Masoud H, Martin A, Richards JC, Moxon ER, Schweda EK: Structural analysis of the lipopolysaccharide oligosaccharide epitopes expressed by a capsule-deficient strain of Haemophilus influenzae Rd. Eur J Biochem 261:171-180, 1999.
8. Masoud H, Moxon ER, Martin A, Krajcarski D, Richards JC: Structure of the variable and conserved lipopolysaccharide oligosaccharide epitopes expressed by Haemophilus influenzae serotype b strain Eagan. Biochemistry 36:2091-2103, 1997.
9. Swords WE, Buscher BA, Ver Steeg Ii K, Preston A, Nichols WA, Weiser JN, Gibson BW, Apicella MA: Non-typeable Haemophilus influenzae adhere to and invade human bronchial epithelial cells via an interaction of lipooligosaccharide with the PAF receptor. Mol Microbiol 37:13-27, 2000.
10. Gould JM, Weiser JN: The inhibitory effect of C-reactive protein on bacterial phosphorylcholine platelet-activating factor receptor-mediated adherence is blocked by surfactant. J Infect Dis 186:361-371, 2002.
11. Ketterer MR, Shao JQ, Hornick DB, Buscher B, Bandi VK, Apicella MA: Infection of primary human bronchial epithelial cells by Haemophilus influenzae: macropinocytosis as a mechanism of airway epithelial cell entry. Infect Immun 67:4161-4170, 1999.
12. Tong HH, Blue LE, James MA, Chen YP, DeMaria TF: Evaluation of phase variation of nontypeable Haemophilus influenzae lipooligosaccharide during nasopharyngeal colonization and development of otitis media in the chinchilla model. Infect Immun 68:4593-4597, 2000.
13. Ishizuka S, Yamaya M, Suzuki T, Nakayama K, Kamanaka M, Ida S, Sekizawa K, Sasaki H: Acid exposure stimulates the adherence of Streptococcus pneumoniae to cultured human airway epithelial cells: effects on platelet-activating factor receptor expression. Am J Respir Cell Mol Biol 24:459-468, 2001.
14. Cundell DR, Gerard NP, Gerard C, Idanpaan-Heikkila I, Tuomanen EI: Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature 377:435-438, 1995.
15. Ring A, Weiser JN, Tuomanen EI: Pneumococcal trafficking across the blood-brain barrier. Molecular analysis of a novel bidirectional pathway. J Clin Invest 102:347-360, 1998.
16. Schenkein HA, Barbour SE, Berry CR, Kipps B, Tew JG: Invasion of human vascular endothelial cells by Actinobacillus actinomycetecomitans via the receptor for platelet-activating factor. Infect Immun 68:5416-5419, 2000.
17. Rijneveld AW, Weijer S, Florquin S, Speelman P, Shimizu T, Ishii S, van der Poll T: Improved host defense against pneumococcal pneumonia in platelet-activating factor receptor-deficient mice. J Infect Dis 189:711-716, 2004.
18. Cabellos C, MacIntyre DE, Forrest M, Burroughs M, Prasad S, Tuomanen E: Differing roles for platelet-activating factor during inflammation of the lung and subarachnoid space. The special case of Streptococcus pneumoniae. J Clin Invest 90:612-618, 1992.
19. Cundell D, Masure HR, Tuomanen EI: The molecular basis of pneumococcal infection: a hypothesis. Clin Infect Dis 21(Suppl 3):S204-S211, 1995.
20. Bandi V, Apicella MA, Mason E, Murphy TF, Siddiqi A, Atmar RL, Greenberg SB: Nontypeable Haemophilus influenzae in the lower respiratory tract of patients with chronic bronchitis. Am J Respir Crit Care Med 164:2114-2119, 2001.
21. Rao VK, Krasan GP, Hendrixson DR, Dawid S, St Geme JW III: Molecular determinants of the pathogenesis of disease due to non-typable Haemophilus influenzae. FEMS Microbiol Rev 23:99-129, 1999.
22. Turk DC: The pathogenicity of Haemophilus influenzae. J Med Microbiol 18:1-16, 1984.
23. Murphy TF, Apicella MA: Nontypable Haemophilus influenzae: a review of clinical aspects, surface antigens, and the human immune response to infection. Rev Infect Dis 9:1-15, 1987.
24. Ishii S, Kuwaki T, Nagase T, Maki K, Tashiro F, Sunaga S, Cao WH, Kume K, Fukuchi Y, Ikuta K, Miyazaki J, Kumada M, Shimizu T: Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor. J Exp Med 187:1779-1788, 1998.
25. Kroll JS, Moxon ER: Capsulation and gene copy number at the cap locus of Haemophilus influenzae type b. J Bacteriol 170:859-864, 1988.
26. Barenkamp SJ, Leininger E: Cloning, expression, and DNA sequence analysis of genes encoding nontypeable Haemophilus influenzae high-molecular-weight surface-exposed proteins related to filamentous hemagglutinin of Bordetella pertussis. Infect Immun 60:1302-1313, 1992.
27. Lichtman SN, Wang J, Hummel B, Lacey S, Sartor RB: A rat model of ileal pouch-rectal anastomosis. Inflamm Bowel Dis 4:187-195, 1998.
28. Rijneveld AW, Florquin S, Bresser P, Levi M, de Waard V, Lijnen R, Van der Zee JS, Speelman P, Carmeliet P, van der Poll T: Plasminogen activator inhibitor type-1 deficiency does not influence the outcome of murine pneumococcal pneumonia. Blood 102:934-939, 2003.
29. Zhang P, Summer WR, Bagby GJ, Nelson S: Innate immunity and pulmonary host defense. Immunol Rev 173:39-51, 2000.
30. Strieter RM, Belperio JA, Keane MP: Cytokines in innate host defense in the lung. J Clin Invest 109:699-705, 2002.
31. Wang X, Moser C, Louboutin J-P, Lysenko ES, Weiner DJ, Weiser JN, Wilson JM: Toll-like receptor 4 mediates innate immune responses to Haemophilus influenzae infection in mouse lung. J Immunol 168:810-815, 2002.
32. Imasato A, Desbois-Mouthon C, Han J, Kai H, Cato AC, Akira S, Li JD: Inhibition of p38 MAPK by glucocorticoids via induction of MAPK phosphatase-1 enhances nontypeable Haemophilus influenzae-induced expression of toll-like receptor 2. J Biol Chem 277:47444-47450, 2002.
33. Shuto T, Imasato A, Jono H, Sakai A, Xu H, Watanabe T, Rixter DD, Kai H, Andalibi A, Linthicum F, Guan YL, Han J, Cato AC, Lim DJ, Akira S, Li JD: Glucocorticoids synergistically enhance nontypeable Haemophilus influenzae-induced Toll-like receptor 2 expression via a negative cross-talk with p38 MAP kinase. J Biol Chem 277:17263-17270, 2002.
34. Akira S, Hemmi H: Recognition of pathogen-associated molecular patterns by TLR family. Immunol Lett 85:85-95, 2003.
35. Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F: Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 274:10689-10692, 1999.
36. Du X, Poltorak A, Silva M, Beutler B: Analysis of Tlr4-mediated LPS signal transduction in macrophages by mutational modification of the receptor. Blood Cell Mol Dis 25:328-338, 1999.
37. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K, Akira S: Cutting edge: toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 162:3749-3752, 1999.
38. Hirschfeld M, Ma Y, Weis JH, Vogel SN, Weis JJ: Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J Immunol 165:618-622, 2000.
39. Tapping RI, Akashi S, Miyake K, Godowski PJ, Tobias PS: Toll-like receptor 4, but not toll-like receptor 2, is a signaling receptor for Escherichia and Salmonella lipopolysaccharides. J Immunol 165:5780-5787, 2000.
40. Soares AC, Pinho VS, Souza DG, Shimizu T, Ishii S, Nicoli JR, Teixeira MM: Role of the platelet-activating factor (PAF) receptor during pulmonary infection with gram negative bacteria. Br J Pharmacol 137:621-628, 2002.
41. Miotla JM, Jeffery PK, Hellewell PG: Platelet-activating factor plays a pivotal role in the induction of experimental lung injury. Am J Respir Cell Mol Biol 18:197-204, 1998.
42. Rylander R, Beijer L, Lantz RC, Burrell R, Sedivy P: Modulation of pulmonary inflammation after endotoxin inhalation with a platelet-activating factor antagonist (48740 RP). Int Arch Allergy Appl Immunol 86:303-307, 1988.
43. Nagase T, Ishii S, Kume K, Uozumi N, Izumi T, Ouchi Y, Shimizu T: Platelet-activating factor mediates acid-induced lung injury in genetically engineered mice. J Clin Invest 104:1071-1076, 1999.
44. Tavares de Lima W, Steil AA, Russo M, Starobinas N, Teixeira CF, Jancar S: Lipid mediators, tumor necrosis factor and nitric oxide and their interactions in immune-complex-induced lung injury. Eur J Pharmacol 358:69-75, 1998.
45. Lonardoni MV, Russo M, Jancar S: Essential role of platelet-activating factor in control of Leishmania (Leishmania) amazonensis infection. Infect Immun 68:6355-6361, 2000.
46. Aliberti JC, Machado FS, Gazzinelli RT, Teixeira MM, Silva JS: Platelet-activating factor induces nitric oxide synthesis in Trypanosoma cruzi-infected macrophages and mediates resistance to parasite infection in mice. Infect Immun 67:2810-2814, 1999.
47. Weijer S, Leemans JC, Florquin S, Shimizu T, Ishii S, van der Poll T: Host response of platelet-activating factor receptor-deficient mice during pulmonary tuberculosis. Immunology 109:552-556, 2003.